Source: Annual Congress 2004 - Treatment of lung cancer and lung metastases
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. A. Vishnevsky, M. Y. Pikunov (Moscow, Russia). New approach to differential diagnosis of lung focal tumors on the basis of investigations of glutation metabolism ferments. Eur Respir J 2004; 24: Suppl. 48, 378

Member's Comments

No comment yet.

Related content which might interest you: Scintigraphic parameters in differential diagnostics of community acquired pneumonia and lung cancer Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Differential diagnosis of granulomatous lung disease: clues and pitfalls Source: Eur Respir Rev, 26 (145) 170012; 10.1183/16000617.0012-2017 Year: 2017 The role of molecular pathology in diagnosis and treatment of lung cancer Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases Year: 2007 Contribution of immunological examination to the diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 65s Year: 2001 New insights into lung cancer: what radiologists can contribute to diagnosis and staging Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 New findings in the molecular biology of lung cancer: clinical application Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Small cell lung cancer – possibility and difficulties in cytological diagnosis Source: Eur Respir J 2006; 28: Suppl. 50, 81s Year: 2006 Role of biomarkers for early detection of lung cancer and chemoprevention Source: Eur Respir J 2002; 19: 1151-1158 Year: 2002 Feasibility study of cryobiopsy for practical pathological diagnosis including immunohistochemical assessment of primary lung cancer Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018 The Choice of lung biopsy method in the presence of limited focal lesions. Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019 Immunophenotyping and genic re-arrangement analysis in lymphocytic/lymphoproliferative disorders of the lungs Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease Year: 2007 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Cytology in differential diagnosis of histological types of NSCLC Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 New approaches to tuberculosis diagnosis through the study of metabolomic profile in urine Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 History of lung adenocarcinoma classification. Overview and pathology of new ERS/ATS/IASLC proposal Source: Annual Congress 2009 - The new ERS/ATS/IASLC classification of lung adenocarcinoma: practice update Year: 2009 Solid and subsolid pulmonary nodules: differential diagnosis and radiological approach to diagnosis Source: International Congress 2018 – Imaging Grand Round Year: 2018 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021